Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,411
Closed -$220K – 267
2025
Q2
$220K Sell
1,411
-80
-5% -$12.7K 0.03% 207
2025
Q1
$245K Sell
1,491
-8
-0.5% -$1.33K 0.04% 186
2024
Q4
$244K Buy
1,499
+58
+4% +$10.4K 0.04% 198
2024
Q3
$281K Buy
1,441
+98
+7% +$18.1K 0.05% 164
2024
Q2
$233K Sell
1,343
-30
-2% -$4.99K 0.05% 201
2024
Q1
$232K Buy
+1,373
New +$257K 0.05% 206
2023
Q4
– Sell
-1,275
Closed -$222K – 206
2023
Q3
$222K Buy
1,275
+58
+5% +$10.5K 0.06% 147
2023
Q2
$210K Buy
1,217
+4
+0.3% +$692 0.07% 148
2023
Q1
$202K Buy
+1,213
New +$199K 0.06% 131
2022
Q4
– Sell
-1,440
Closed -$214K – 148
2022
Q3
$214K Sell
1,440
-3
-0.2% -$501 0.06% 117
2022
Q2
$248K Sell
1,443
-14
-1% -$2.42K 0.07% 108
2022
Q1
$275K Sell
1,457
-473
-25% -$93.5K 0.07% 114
2021
Q4
$452K Buy
1,930
+64
+3% +$14K 0.13% 82
2021
Q3
$362K Hold
1,866
– – 0.12% 89
2021
Q2
$348K Buy
1,866
+7
+0.4% +$1.22K 0.12% 91
2021
Q1
$293K Buy
1,859
+6
+0.3% +$951 0.12% 94
2020
Q4
$307K Buy
+1,853
New +$301K 0.13% 90

Other funds holding ZTS

MJP Associates's ZTS Position: Q3 2025 in Review

MJP Associates sold out of Zoetis (ZTS) in Q3 2025, closing a stake of 1,411 shares — an estimated $220K sold.

MJP Associates first reported a position in ZTS in Q4 2020 and held it in 17 quarters. The position peaked at $452K in Q4 2021. 1,806 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.

  • MJP Associates reported no remaining Zoetis position as of Q3 2025 after selling out during the quarter.
  • MJP Associates sold 1,411 Zoetis shares in Q3 2025, an estimated $220K.
  • MJP Associates first reported a position in Zoetis in Q4 2020 and held it in 17 quarters.
  • MJP Associates's Zoetis position peaked at $452K in Q4 2021.
  • 1,806 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.

Based on MJP Associates's 13F filing for Q3 2025, filed 7 Nov 2025.